Enzastaurin and Bevacizumab in Treating Patients With Locally Advanced or Metastatic Cancer
Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
Interventions
- BIOLOGICAL: bevacizumab
- DRUG: enzastaurin hydrochloride
- OTHER: diagnostic laboratory biomarker analysis
- OTHER: pharmacological study
Sponsor
Eli Lilly and Company
Collaborators